BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25274557)

  • 1. From hypomagnesaemia to Zollinger-Ellison syndrome: an adverse effect of a proton pump inhibitor.
    Eyal A; Sueissa A; Braun E; Naffaa ME
    BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25274557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.
    Banasch M; Schmitz F
    Wien Klin Wochenschr; 2007; 119(19-20):573-8. PubMed ID: 17985090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe symptomatic hypomagnesaemia induced by the chronic use of proton pump inhibitors: a case report of a patient with Zollinger-Ellison syndrome.
    Ströker E; Leone L; Vandeput Y; Borbath I; Lefebvre C
    Acta Clin Belg; 2014; 69(1):62-5. PubMed ID: 24635401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Duodenal gastrinoma with the development of Zollinger-Ellison syndrome].
    Ponomarev AB; Sklianskaia OA; Iushkov PV
    Arkh Patol; 1994; 56(2):62-4. PubMed ID: 8037598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of Zollinger-Ellison syndrome produced by gastrinoma in the duodenum accompanied with multiple endocrine neoplasia type 1.
    Yazawa K; Kuroda T; Watanabe H; Shimozawa N; Nakata S; Fujimori Y; Koide N; Koike S; Kajikawa S; Adachi W; Amano J
    Hepatogastroenterology; 1999; 46(25):257-60. PubMed ID: 10228803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrinoma and Zollinger-Ellison syndrome in canids: a literature review and a case in a Mexican gray wolf.
    Struthers JD; Robl N; Wong VM; Kiupel M
    J Vet Diagn Invest; 2018 Jul; 30(4):584-588. PubMed ID: 29860931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zollinger-Ellison syndrome, duodenal carcinoid (gastrinoma), and hyperthyroidism.
    Theile R; Scharplatz D; Stamm B; Veraguth UP
    Virchows Arch A Pathol Anat Histopathol; 1989; 415(6):577-8. PubMed ID: 2508315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total gastrectomy for severe proton pump inhibitor-induced hypomagnesemia in a MEN1/Zollinger Ellison syndrome patient.
    Perrier M; Delemer B; Deguelte S; Legros V; Brixi H; Kianmanesh R; Cadiot G
    Pancreatology; 2021 Jan; 21(1):236-239. PubMed ID: 33309626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case presentation of gastrinoma combined with gastric carcinoid with the longest survival record -- Zollinger-Ellison syndrome: pathophysiology, diagnosis and therapy.
    Konturek SJ; Konturek PC; Bielański W; Lorens K; Sito E; Konturek JW; Kwiecień S; Bobrzyński A; Pawlik T; Karcz D; Areny H; Stachura T
    Med Sci Monit; 2002 Jun; 8(6):CS43-59. PubMed ID: 12070442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome.
    Hirschowitz BI; Mohnen J; Shaw S
    Aliment Pharmacol Ther; 1996 Aug; 10(4):507-22. PubMed ID: 8853754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome?
    Corleto VD; Annibale B; Gibril F; Angeletti S; Serrano J; Venzon DJ; Delle Fave G; Jensen RT
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1555-61. PubMed ID: 11563994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.
    Tomassetti P; Salomone T; Migliori M; Campana D; Corinaldesi R
    Drugs Aging; 2003; 20(14):1019-34. PubMed ID: 14651442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing for Multiple Endocrine Neoplasia Type 1 in Patients Evaluated for Zollinger-Ellison Syndrome-Clues to a Safer Diagnostic Process.
    Singh Ospina N; Donegan D; Rodriguez-Gutierrez R; Al-Hilli Z; Young WF
    Am J Med; 2017 May; 130(5):603-605. PubMed ID: 28011308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rare occurrence of fulminant acid burn of the esophagus].
    Knebel C; Bumm R; Becker K; Burian M; Siewert JR
    Chirurg; 2008 Aug; 79(8):765-70. PubMed ID: 17879075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h.
    Hirschowitz BI; Mohnen J; Shaw S
    Aliment Pharmacol Ther; 1996 Aug; 10(4):497-506. PubMed ID: 8853753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zollinger-Ellison syndrome. Clinical presentation in 261 patients.
    Roy PK; Venzon DJ; Shojamanesh H; Abou-Saif A; Peghini P; Doppman JL; Gibril F; Jensen RT
    Medicine (Baltimore); 2000 Nov; 79(6):379-411. PubMed ID: 11144036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ulcerogenic tumor of the duodenum.
    Evans WE; Armstrong RG; Schulte W; Garancis JC
    Am J Surg; 1972 Nov; 124(5):596-9. PubMed ID: 5079791
    [No Abstract]   [Full Text] [Related]  

  • 19. Image of the month. Wermer syndrome and Zollinger-Ellison syndrome.
    Frankel TL; Gauger PG
    Arch Surg; 2009 Apr; 144(4):377-8. PubMed ID: 19380653
    [No Abstract]   [Full Text] [Related]  

  • 20. Duodenal microgastrinomas associated with Zollinger-Ellison syndrome.
    Schröder W; Hölscher AH; Beckurts T; Richter TH; Höfler H; Siewert JR
    Hepatogastroenterology; 1996; 43(12):1465-9. PubMed ID: 8975949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.